Long-term prophylactic treatment of attacks of vertigo in Menière's disease – comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol (In press).

Vertigo presents a trans-disciplinary challenge ... We fail to understand, however, why the Cochrane analysis on betahistine was not included in the certified CME article, whereas it was included ...

Betahistine is a medicine used to treat a condition called Ménière’s disease. The symptoms include dizziness (vertigo), ringing in the ears (tinnitus) and loss of hearing, probably caused by ...